SCHEMBL8096449

SCHEMBL8096449

CCNC(=O)c1ccccc1NCC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 3/20 0.59
ADRA1A P35348 3/20 0.59
ADRA1B P35368 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.50
KMT2A Q03164 1/20 0.50
CXCR2 P25025 1/20 0.50
JAK2 O60674 2/20 0.49
JAK1 P23458 2/20 0.49
GAA P10253 2/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
BRD4 O60885 2/20 0.47
PTK2 Q05397 1/20 0.46
ALDH1A1 P00352 1/20 0.46
FABP4 P15090 1/20 0.44
CA1 P00915 1/20 0.44
CA9 Q16790 1/20 0.44
KDM4E B2RXH2 1/20 0.44
GLA P06280 1/20 0.44
HCRTR1 O43613 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11251488 0.86 KDM4E (0.62) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL3478287 0.85 ADRA1D (0.56) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL960584 0.85 CTSD (0.51) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL6607848 0.85 ADRA1D (0.55) ADRA1DADRA1AADRA1BKMT2ACXCR2
SCHEMBL7223357 0.85 ADRA1D (0.53) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL31483721 0.84 HTT (0.64) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL26417076 0.84 HTT (0.64) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL17182409 0.84 ADRA1D (0.52) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL23740293 0.82 ADRA1D (0.48) ADRA1DADRA1AADRA1BL3MBTL1KMT2A
SCHEMBL2001238 0.82 FABP4 (0.48) ADRA1DADRA1AADRA1BL3MBTL1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003024448-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2003-03-27 WO disclosed
US-6030973-A TYPE II DIABETES (NON-INSULIN-DEPENDENT-DIABETES MELLITUS) POTENTIATION; EFFICIENCY; SIDE EFFECT REDUCTION DR. REDDY'S RESEARCH FOUNDATION (IN) 2000-02-29 US disclosed